Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma

Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting

(2010) D. Santini et al.   CURRENT CANCER DRUG TARGETS

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials

(2009) M. Gnant   CURRENT CANCER DRUG TARGETS

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF

(2009) Luigi Dolcetti et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Myeloid-derived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development

(2009) Verena Greifenberg et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Role of macrophages in tumour progression

(2009) K.S. Siveen et al.   IMMUNOLOGY LETTERS

Zoledronic acid, an aminobisphosphonate, modulates differentiation and maturation of human dendritic cells

(2009) Yu-Jen Chen et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Regulatory T cells: how do they suppress immune responses?

(2009) S. Sakaguchi et al.   INTERNATIONAL IMMUNOLOGY

Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model

(2009) Penelope D. Ottewell et al.   INTERNATIONAL JOURNAL OF CANCER

Chorionic gonadotropin alleviates thioglycollate-induced peritonitis by affecting macrophage function

(2009) Hui Wan et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer

(2009) Kishan J. Pandya et al.   LUNG CANCER

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

(2009) Michael Gnant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Zoledronic Acid Is Effective against Experimental Malignant Pleural Effusion

(2008) Georgios T. Stathopoulos et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow--a long-term follow-up

(2008) I. J. Diel et al.   ANNALS OF ONCOLOGY

Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages

(2008) Panagiotis Tsagozis et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Macrophage-Derived SPARC Bridges Tumor Cell-Extracellular Matrix Interactions toward Metastasis

(2008) Sabina Sangaletti et al.   CANCER RESEARCH

Regulatory T Cells and Immune Tolerance

(2008) Shimon Sakaguchi et al.   CELL

The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages

(2008) Paola Allavena et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance

(2008) Paola Allavena et al.   IMMUNOLOGICAL REVIEWS

Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics

(2008) Naoki Umemura et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma

(2008) N. R. Miselis et al.   MOLECULAR CANCER THERAPEUTICS

Nitric oxide, apoptosis and macrophage polarization during tumor progression

(2008) Andreas Weigert et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Macrophage polarization in tumour progression

(2008) Antonio Sica et al.   SEMINARS IN CANCER BIOLOGY